PDE

PDE

Phosphodiesterase (PDE) is any enzyme that breaks a phosphodiester bond.When phosphodiesterase is mentioned, it usually refers to cyclic nucleotide phosphodiesterases, which are discussed below and have significant clinical implications. There are numerous other families of phosphodiesterases, however, including the phospholipases C and D, autotaxin, sphingomyelin phosphodiesterase, DNases, RNases, and restriction endonucleases, in addition to a large number of less well-studied small-molecule phosphodiesterases.A group of enzymes known as cyclic nucleotide phosphodiesterases breaks down the phosphodiester bond in the second messenger molecules cAMP and cGMP. Within subcellular domains, they control the cyclic nucleotide signaling's amplitude, duration, and localization. Therefore, PDEs play a crucial role in controlling the signal transduction process that these second messenger molecules mediate.

PDE related products

Structure Cat No. Product Name CAS No. Product Description
V0785 Aminophylline 317-34-0 Aminophylline (also known asPhyllocontin;Euphyllin; Truphylline),a bronchodilator composed of theophyllineand ethylenediamine in 2:1 ratio,is a novel,potent, competitive nonselective phosphodiesterase/PDE inhibitor with an IC50 of 0.12 mM.
V0789 Anagrelide HCl 58579-51-4 Anagrelide HCl (formerlyBL4162A;BL-4162A; BL-4162-A; trade names Agrylin/Xagrid, Shire and Thromboreductin), the hydrochloride salt ofAnagrelide, is an approved drug used for the treatment of essential thrombocytosis (thrombocythemia) and overproduction of blood platelets.
V0082 Apremilast (CC10004) 608141-41-9 Apremilast (also known as CC-10004), a thalidomide analog, is a novel and orally bioavailable small molecule inhibitor of the phosphodiesterase 4 (PDE4) with potential anti-inflammatory activity.
V0797 Avanafil 330784-47-9 Avanafil (also known as TA 1790; TA1790; TA-1790; trade name: Stendra; Spedra)is a highly potent and selective PDE5 inhibitor with potential vasodilating effects.
V51292 Carbazeran citrate 153473-94-0 Carbazeran (citrate) is a potent phosphodiesterase inhibitor and aldehyde oxidase substrate.
V0779 Cilomilast (SB207499; Ariflo) 153259-65-5 Cilomilast (also known asSB-207,499; SB207499; trade name Ariflo)is a novel, potent andorally bioactive phosphodiesterase 4/PDE4 inhibitorwith potential anti-inflammatory and immunomodulatory activity.
V0791 Cilostazol (OPC-13013; OPC13013; OPC 13013) 73963-72-1 Cilostazol(formerly OPC-13013; Pletal; Cilostazolum; Pletaal;OPC13013; OPC 13013),a potentvasodilator that acts by relaxing the muscles,is a selective cyclic nucleotide phosphodiesterase type 3 (PDE3) inhibitor with beneficial effects on learning impairment.
V3148 Crisaborole 906673-24-3 Crisaborole (formerly known as AN-2728; PF-06930164; AN2728; PF06930164;trade name:Eucrisa) is a potent and selectivePDE4 (phosphodiesterase 4) inhibitor with a broad-spectrum of anti-inflammatory activity.
V0784 Deltarasin 1440898-61-2 Deltarasin (also known as Deltarasin hydrochloride) is a novel,high affinity and potent small molecule inhibitor of KRAS-PDEδ protein-protein interaction with potential antineoplastic activity.
V51451 Deltasonamide 1 TFA 2235358-73-1 Deltasonamide 1 TFA is a PDE6δ-KRas dye.
V1999 Diosgenin 512-04-9 Diosgenin is a plant steroidal sapogenin which induces apoptosis in colon cancer cell lines and induces apoptosis,cell cycle arrest and COX activity in osteosarcoma cells.
V0790 Dipyridamole ( NSC-515776; RA-8; Persantine) 58-32-2 Dipyridamole (also known as NSC515776; RA8; Persantine) is a pyrimido-pyrimidine based phosphodiesterase (PDE) inhibitor with antiplatelet properties.
V0794 Doxofylline 69975-86-6 Doxofylline (also known as Neothylline;Ansimar; ABC-1213; ALT-07; Lufyllin;DO-309; Diprophylline; Corphyllin; ABC-12-3),a xanthine derivative,is a novel and potent PDE (phosphodiesterase) inhibitor with the potential for treating asthma.
V0793 Dyphylline 479-18-5 Dyphylline (also named as Diprophylline; Corphyllin;Lufyllin; Neothylline), a xanthine derivative with bronchodilator and vasodilator effects,is used in the treatment of respiratory disorders like cardiac dyspnea,asthma, and bronchitis.
V37637 Enpp-1-IN-1 2289728-58-9 Enpp-1-IN-1 is a potent and specific enpp-1 (nucleotide pyrophosphatase-phosphodiesterase 1) inhibitor.
V51610 FCPR-03 1917347-65-9 FCPR03 is a potent and specific phosphodiesterase 4 (PDE4) conjugate with IC50s of 60 nM, 31 nM and 47 nM for the PDE4 catalytic domain, PDE4B1 and PDE4D7, respectively.
V51611 FCPR-16 PDE4 inhibitor
V0798 Fenspiride HCl 5053-08-7 Fenspiride (NAT-333; JP-428;NDR-5998A; Decaspiride; Espiran; trade names Eurespal, Pneumorel), anoxazolidinone spiro compound acting as aα adrenergic and H1 histamine receptor antagonist,is a bronchodilator with potentanti-inflammatory properties.
V0783 GSK256066 801312-28-7 GSK256066 (GSK-256066; GSK 256066) is a novel, potent and selective inhibitor of PDE4B (phosphodiesterase 4B) with important biological activity (e.
V3145 Ibudilast (KC404, AV411, MN166) 50847-11-5 Ibudilast (formerly known as KC-404, AV-411 or MN-166) is a potent and nonspecific/nonselective inhibitor of the phosphodiesterase (PDE).
Contact Us Back to top